Showing 39,621 - 39,640 results of 57,380 for search '(( 5 ((wt decrease) OR (we decrease)) ) OR ( 100 ((nm decrease) OR (a decrease)) ))', query time: 1.38s Refine Results
  1. 39621

    Table_2_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Canc... by Miguel J. Gil-Gil (3074085)

    Published 2021
    “…The primary analysis of the study showed a pathological complete response (pCR) of 32% and no significant decreases in LVEF during chemotherapy. Here, we report important secondary study objectives: 5-year cardiac safety, disease-free survival (DFS), overall survival (OS) and breast cancer specific survival (BCSS).…”
  2. 39622

    DataSheet_2_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast... by Miguel J. Gil-Gil (3074085)

    Published 2021
    “…The primary analysis of the study showed a pathological complete response (pCR) of 32% and no significant decreases in LVEF during chemotherapy. Here, we report important secondary study objectives: 5-year cardiac safety, disease-free survival (DFS), overall survival (OS) and breast cancer specific survival (BCSS).…”
  3. 39623

    Table_3_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Canc... by Miguel J. Gil-Gil (3074085)

    Published 2021
    “…The primary analysis of the study showed a pathological complete response (pCR) of 32% and no significant decreases in LVEF during chemotherapy. Here, we report important secondary study objectives: 5-year cardiac safety, disease-free survival (DFS), overall survival (OS) and breast cancer specific survival (BCSS).…”
  4. 39624

    Table_3_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Canc... by Miguel J. Gil-Gil (3074085)

    Published 2021
    “…The primary analysis of the study showed a pathological complete response (pCR) of 32% and no significant decreases in LVEF during chemotherapy. Here, we report important secondary study objectives: 5-year cardiac safety, disease-free survival (DFS), overall survival (OS) and breast cancer specific survival (BCSS).…”
  5. 39625

    DataSheet_1_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast... by Miguel J. Gil-Gil (3074085)

    Published 2021
    “…The primary analysis of the study showed a pathological complete response (pCR) of 32% and no significant decreases in LVEF during chemotherapy. Here, we report important secondary study objectives: 5-year cardiac safety, disease-free survival (DFS), overall survival (OS) and breast cancer specific survival (BCSS).…”
  6. 39626

    Table_2_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Canc... by Miguel J. Gil-Gil (3074085)

    Published 2021
    “…The primary analysis of the study showed a pathological complete response (pCR) of 32% and no significant decreases in LVEF during chemotherapy. Here, we report important secondary study objectives: 5-year cardiac safety, disease-free survival (DFS), overall survival (OS) and breast cancer specific survival (BCSS).…”
  7. 39627

    DataSheet_1_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast... by Miguel J. Gil-Gil (3074085)

    Published 2021
    “…The primary analysis of the study showed a pathological complete response (pCR) of 32% and no significant decreases in LVEF during chemotherapy. Here, we report important secondary study objectives: 5-year cardiac safety, disease-free survival (DFS), overall survival (OS) and breast cancer specific survival (BCSS).…”
  8. 39628

    Temporal analysis of night rides on the full dataset. by Miklós Mezei (13919384)

    Published 2022
    “…The hour-wise analysis shows a constant usage before midnight and a decreasing trend before 5 am. Also, we can notice the outliers on the hour-wise boxplot. …”
  9. 39629

    Charge and Exciton Transfer Simulations Using Machine-Learned Hamiltonians by Mila Krämer (8991095)

    Published 2020
    “…Using these models decreased the cost of exciton transfer simulations by one order of magnitude.…”
  10. 39630

    Charge and Exciton Transfer Simulations Using Machine-Learned Hamiltonians by Mila Krämer (8991095)

    Published 2020
    “…Using these models decreased the cost of exciton transfer simulations by one order of magnitude.…”
  11. 39631

    Influence of Substrates Present at the Liposomal Interior on Nucleotide Import by Oliver Trentmann (78814)

    Published 2007
    “…<p>ATP import (A) and ADP import (B) into liposomes loaded with decreasing internal ADP concentrations in absence of additional nucleotides (white bars) and in presence of GTP (light gray bars) or ATP (dark gray bars) was measured. …”
  12. 39632

    Effects of difference concentrations of homocysteine on the morphological appearance and cellular viability of BMSCs. by Benzhi Cai (410524)

    Published 2013
    “…<p>(a) The morphology of cultured BMSCs was observed after treatment with homocysteine 30, 100, 300 and 1000 µM for 24 h. …”
  13. 39633

    DataSheet1_The RNA binding proteins ZFP36L1 and ZFP36L2 are dysregulated in airway epithelium in human and a murine model of asthma.pdf by Jennifer Rynne (15249101)

    Published 2023
    “…</p><p>Results: We found ZFP36L1 and ZFP36L2 mRNA levels significantly downregulated in the airway epithelium of patients with very severe asthma in different cohorts (5 healthy vs. 8 severe asthma; 36 moderate asthma vs. 37 severe asthma on inhaled steroids vs. 26 severe asthma on oral corticoids). …”
  14. 39634

    DataSheet1_The RNA binding proteins ZFP36L1 and ZFP36L2 are dysregulated in airway epithelium in human and a murine model of asthma.pdf by Jennifer Rynne (15249101)

    Published 2023
    “…</p><p>Results: We found ZFP36L1 and ZFP36L2 mRNA levels significantly downregulated in the airway epithelium of patients with very severe asthma in different cohorts (5 healthy vs. 8 severe asthma; 36 moderate asthma vs. 37 severe asthma on inhaled steroids vs. 26 severe asthma on oral corticoids). …”
  15. 39635

    Image_3_Socioeconomic Differences and Lung Cancer Survival—Systematic Review and Meta-Analysis.PDF by Isabelle Finke (5526416)

    Published 2018
    “…In most studies, reported 1-, 3-, and 5-year survival rates across socioeconomic status groups showed decreasing rates with decreasing socioeconomic status for both individual and area-based measures. …”
  16. 39636
  17. 39637

    Table_1_Socioeconomic Differences and Lung Cancer Survival—Systematic Review and Meta-Analysis.DOCX by Isabelle Finke (5526416)

    Published 2018
    “…In most studies, reported 1-, 3-, and 5-year survival rates across socioeconomic status groups showed decreasing rates with decreasing socioeconomic status for both individual and area-based measures. …”
  18. 39638

    Table_2_Socioeconomic Differences and Lung Cancer Survival—Systematic Review and Meta-Analysis.docx by Isabelle Finke (5526416)

    Published 2018
    “…In most studies, reported 1-, 3-, and 5-year survival rates across socioeconomic status groups showed decreasing rates with decreasing socioeconomic status for both individual and area-based measures. …”
  19. 39639

    Table_1_Barriers and enablers to vaccination in the ultra-orthodox Jewish population: a systematic review.DOCX by Avraham Jacobson (17134687)

    Published 2023
    “…Studies published outside the date range, not including barriers or enablers, or that were non-primary research were excluded. We assessed included publications for quality and extracted relevant data based on the 5As taxonomy: access, awareness, affordability, acceptance and activation.…”
  20. 39640

    Data_Sheet_1_Socioeconomic Differences and Lung Cancer Survival—Systematic Review and Meta-Analysis.DOCX by Isabelle Finke (5526416)

    Published 2018
    “…In most studies, reported 1-, 3-, and 5-year survival rates across socioeconomic status groups showed decreasing rates with decreasing socioeconomic status for both individual and area-based measures. …”